Appili Therapeutics
2015
FOUNDED
PUBLIC
STATUS
11-20
EMPLOYEES
APLI
STOCK SYMBOL
$0.60
SHARE PRICE
(As of Friday Closing)
Description
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes three major programs namely ATI-1501, ATI1503, and ATI-1701.
Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TSX
Primary Office
- Suite 21-1344 Summer Street
- Halifax, Nova Scotia B3H 0A8
- Canada
+1 (902) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Appili Therapeutics’s full profile, request a free trial.
Appili Therapeutics Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.24 - $0.83 | $20M | $0.60 | -$0.12 | 38.7K | 33.6M |
Appili Therapeutics Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2019
31-Mar-2019
|
FY 2018
31-Mar-2018
|
|---|---|---|---|
| Enterprise Value | 9,230 | ||
| Revenue | 0 | 0 | 0 |
| EBITDA | (4,046) | (3,315) | (2,921) |
| Net Income | (4,115) | (3,299) | (3,097) |
| Total Assets | 2,861 | 5,119 | 5,568 |
| Total Debt | 761 | 838 | 861 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Appili Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Appili Therapeutics‘s full profile, request access.
Request full access to PitchBookAppili Therapeutics Competitors (30)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Morphotek | Formerly VC-backed | Exton, PA | 000 | 0000 | 000000&0 | 0000 |
| 00000 000000000 | Formerly VC-backed | Boulder, CO | 000 | 00000 | 000000&0 | 00000 |
| 00000000 000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000000 | |
| 000 (0000000000000 | Formerly VC-backed | San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
| 00000 00000 000000 | Venture Capital-Backed | Geneva, Switzerland | 000 | 00000 | 0000000000 0 | 00000 |
Appili Therapeutics Executive Team (5)
Appili Therapeutics Board Members (11)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Armand Balboni Ph.D | Appili Therapeutics | Board Member & Executive | 000 0000 | |
| Brian Bloom | Bloom Burton & Co. | Board Member | 000 0000 | |
| Ian Mortimer | Self | Board Member | 000 0000 | |
| John Holyoake Ph.D | Bloom Burton & Co. | Board Member | 000 0000 | |
| Juergen Froehlich MD | Self | Board Member | 000 0000 |
2 Former Board Members
You’re viewing 5 of 11 board members. Get the full list »